Surgery Total Revenue from 2010 to 2024

SGRY Stock  USD 23.39  0.38  1.65%   
Surgery Partners Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue will likely drop to about 1.6 B in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Surgery Partners' primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2013-12-31
Previous Quarter
762.1 M
Current Value
770.4 M
Quarterly Volatility
193.2 M
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Surgery Partners over the last few years. Total revenue comprises all receipts Surgery Partners generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Surgery Partners' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Surgery Total Revenue Regression Statistics

Arithmetic Mean1,298,503,787
Geometric Mean947,315,632
Coefficient Of Variation67.01
Mean Deviation735,421,935
Median1,341,219,000
Standard Deviation870,062,980
Sample Variance757009.6T
Range2.5B
R-Value0.92
Mean Square Error125219.7T
R-Squared0.85
Slope178,988,006
Total Sum of Squares10598134.2T

Surgery Total Revenue History

20241.6 B
20232.7 B
20222.5 B
20212.2 B
20201.9 B
20191.8 B
20181.8 B

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.7 B1.6 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.